It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
weather icon

26

CLOUDY

TOKYO (11 p.m.)

TODAY'S PRINT EDITION

The Japan Times The Japan Times

Sinovac

  • Login
  • SUBSCRIBE
  • My Account
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

World / Science & Health Jan 11, 2022

Singapore breaks down COVID-19 deaths by vaccine, with Moderna seeing lowest rate

by Low De Wei

While there were some caveats, the findings will likely add to concerns around the efficacy of Sinovac’s and Sinopharm Group’s shots, which have been widely used in the developing world.

China's vaccine diplomacy drive falters as recipients turn to western shots

Asia Pacific Sep 30, 2021

China's vaccine diplomacy drive falters as recipients turn to western shots

by Iain Marlow and Randy Thanthong-Knight

In the early days of COVID-19 vaccine rollouts, Chinese shots saved countless lives. But as the Western stranglehold on mRNA supplies loosens, a clear preference has emerged.

Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths

World Jun 20, 2021

Many Brazilians insist on Pfizer even as nation passes 500,000 COVID-19 deaths

In Sao Paulo, people demand the U.S. company’s shots at public clinics and often walk out if none are available.

Chinese shot takes controversial path to vaccinating the world

Asia Pacific / Science & Health May 13, 2021

Chinese shot takes controversial path to vaccinating the world

Used to operating within China, where public opinion is censored, Chinese vaccine-makers have had a tough time showing their "growth in front of the world," an expert said.

China’s Sinovac shot found highly effective in real world study

Asia Pacific May 12, 2021

China’s Sinovac shot found highly effective in real world study

Indonesian data adds to signs out of Brazil that the shot is more effective than it proved in the testing phase, which was beset by divergent efficacy rates and questions over transparency.

WHO approves Sinopharm vaccine in potential boost to COVAX pipeline

Asia Pacific May 8, 2021

WHO approves Sinopharm vaccine in potential boost to COVAX pipeline

The vaccine, one of two main Chinese coronavirus vaccines, is the first developed by a non-Western country to win WHO backing.

The world turns to China for vaccines after India and U.S. stumble

Asia Pacific May 7, 2021

The world turns to China for vaccines after India and U.S. stumble

by Iain Marlow, Sudhi Ranjan Sen and James Paton

Some experts are worried about the potential impact of widely deploying Chinese shots that have demonstrated lower efficacy rates than those made by Pfizer and Moderna.

Hong Kong offers a masterclass in vaccine confusion

Commentary / World Mar 26, 2021

Hong Kong offers a masterclass in vaccine confusion

by Clara Ferreira Marques

Hong Kong was always going to struggle to run a mass vaccination campaign.

Hong Kong vaccine rollout hampered by reliance on Chinese shots

Asia Pacific Mar 23, 2021

Hong Kong vaccine rollout hampered by reliance on Chinese shots

by Iain Marlow and Jinshan Hong

Confidence in both the Sinovac shot and the government’s vaccine drive has plummeted.

Thailand receives its first coronavirus vaccines

World / Science & Health Feb 24, 2021

Thailand receives its first coronavirus vaccines

Prime Minister Prayuth Chan-ocha is expected to be among the first to receive the vaccine this weekend.

China’s COVID-19 vaccine drive is falling behind the U.S. and Europe

Asia Pacific / Science & Health | FOCUS Feb 8, 2021

China’s COVID-19 vaccine drive is falling behind the U.S. and Europe

The slowness appears to be due to widespread hesitation in the country, including lingering safety concerns, doubts about the level of protection promised and a general lack of urgency.

'I won’t take it': China struggles to get the world to trust its vaccines

Asia Pacific | FOCUS Dec 29, 2020

'I won’t take it': China struggles to get the world to trust its vaccines

by Iain Marlow, Faseeh Mangi and Kari Soo Lindberg

That uncertainty presents another roadblock in China’s efforts to extend its political influence across Asia, Africa and South America.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Japan eases travel advisory for 34 nations, including China and South Korea
    Passengers are welcomed at Seoul's Gimpo Airport after arriving via a freshly resumed flight from Haneda Airport in Tokyo on Wednesday.
  • Japan cautious on starting tourism campaign as fears of virus wave grow
    The central government is taking an increasingly cautious stance on kicking off a tourism promotion campaign amid a possible seventh wave of COVID-19 infections as daily cases rebound nationwide.
  • Up to 39.15 million KDDI mobile lines affected during nationwide disruption
    KDDI Corp. President Makoto Takahashi (right) apologizes over its network disruption during a news conference in Tokyo on Sunday.
  • 'They're everywhere': Microplastics in oceans, air and the human body
    Citizen scientists use tweezers to remove microplastics from a sample at Manly Cove Beach in Sydney in April 2021.
  • As Takefusa Kubo leaves, Mallorca doubles down on commitment to Japan
    RCD Mallorca captain Dani Rodriguez (center) poses with the team's 2022-23 uniform, along with the club's CEO of business Alfonso Diaz (left) and Taica CEO Taito Suzuki, at a media event in Tokyo's Minato Ward on Friday.
  • Japanese research project aims to create Earth-like artificial gravity

    Thumbnail image
  • 'Guerrilla' sales and crowdsourcing: Japan's game console crunch

    Thumbnail image
  • LDP heavyweight Taro Aso likens invasion of Ukraine to bullying of weak

    Thumbnail image
  • Lockdown pain fails to break vaccine resistance among elderly in China

    Thumbnail image
  • Suspect captured in deadly shooting at July 4 parade in Chicago's Highland Park suburb

    Thumbnail image

PODCAST

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Study in Japan JT for Women JT Bookclub Japanese School Directory The Japan Times Jobs
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times